J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 553, Number 3, 857-871, December 15, 2003 DOI: 10.1113/jphysiol.2003.053447
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
553/3/857    most recent
jphysiol.2003.053447v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paradiso, K. G.
Right arrow Articles by Steinbach, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paradiso, K. G.
Right arrow Articles by Steinbach, J. H.
J Physiol (2003), 553.3, pp. 857-871
© Copyright 2003 The Physiological Society
DOI: 10.1113/jphysiol.2003.053447

Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors

K. G. Paradiso and Joe Henry Steinbach

Department of Anesthesiology, Washington University, St Louis, MO 63110, USA

We examined desensitization by acetylcholine (ACh) and nicotine at the rat alpha4beta2 neuronal nicotinic receptor stably expressed in HEK cells. For both agonists, the decay in response due to desensitization ('onset') was best fitted by the sum of two exponentials with the fast component dominant at concentrations > 1 µM. The time constants for onset were similar for both agonists, and showed little concentration dependence over the range of 0.1-100 µM. Recovery from desensitization also showed two exponential components. In contrast to the similarity in onset, nicotine produced longer lasting desensitization, resulting from an increase in the proportion of receptors in the slowly recovering population and from an increase in the time constant for the slow recovery process. The proportion of receptors in the slowly recovering population increased as the duration of the desensitizing pulse increased. Desensitization was also induced by low concentrations of agonist, with no apparent macroscopic response. A 100 s application of 10 nM nicotine desensitized 70 % of the peak response, while 100 s of 10 nM ACh desensitized only 15 %. At higher concentrations of agonist, which result in a macroscopic response, desensitization in the absence of activation also can occur. Nicotine is a very potent and efficacious desensitizing agent at this neuronal nicotinic receptor.



This article has been cited by other articles:


Home page
J. Physiol.Home page
E. A. Gay, R. Giniatullin, A. Skorinkin, and J. L. Yakel
Aromatic residues at position 55 of rat {alpha}7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization
J. Physiol., February 15, 2008; 586(4): 1105 - 1115.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Spivak, C. R. Lupica, and M. Oz
The Endocannabinoid Anandamide Inhibits the Function of {alpha}4beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2007; 72(4): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kishi and J. H. Steinbach
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors
Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, E. D. London, R. E. Olmstead, J. Farahi, D. Scheibal, J. Jou, V. Allen, E. Tiongson, S. I. Chefer, et al.
Cigarette Smoking Saturates Brain {alpha}4beta2 Nicotinic Acetylcholine Receptors.
Arch Gen Psychiatry, August 1, 2006; 63(8): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Sokolova, A. Skorinkin, I. Moiseev, A. Agrachev, A. Nistri, and R. Giniatullin
Experimental and Modeling Studies of Desensitization of P2X3 Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 373 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. B. Pratt, T. S. Brink, P. Bergson, M. M. Voigt, and S. P. Cook
Use-Dependent Inhibition of P2X3 Receptors by Nanomolar Agonist
J. Neurosci., August 10, 2005; 25(32): 7359 - 7365.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. Akk, L. S Milescu, and M. Heckmann
Activation of heteroliganded mouse muscle nicotinic receptors
J. Physiol., April 15, 2005; 564(2): 359 - 376.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 The Physiological Society.